{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:37:42Z","timestamp":1773693462905,"version":"3.50.1"},"reference-count":176,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinology and Metabolism Clinics of North America"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.ecl.2006.06.005","type":"journal-article","created":{"date-parts":[[2007,1,10]],"date-time":"2007-01-10T10:08:25Z","timestamp":1168423705000},"page":"525-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Molecular and Signaling Mechanisms of Atherosclerosis in Insulin Resistance"],"prefix":"10.1016","volume":"35","author":[{"given":"Eric A.","family":"Schwartz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter D.","family":"Reaven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ecl.2006.06.005_bib1","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/dmr.5610030206","article-title":"Diabetes and atherosclerosis: an epidemiologic view","volume":"3","author":"Pyor\u00e4l\u00e4","year":"1987","journal-title":"Diabetes Metab Rev"},{"issue":"19","key":"10.1016\/j.ecl.2006.06.005_bib2","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease. The Framingham study","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ecl.2006.06.005_bib3","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/j.ecl.2006.06.005_bib4","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/01.ATV.12.6.647","article-title":"George Lyman Duff Memorial Lecture. Atherogenesis in diabetes","volume":"12","author":"Bierman","year":"1992","journal-title":"Arterioscler Thromb"},{"issue":"5 Pt 2","key":"10.1016\/j.ecl.2006.06.005_bib5","doi-asserted-by":"crossref","first-page":"S419","DOI":"10.1016\/S0002-8703(99)70266-8","article-title":"Atherosclerosis is an inflammatory disease","volume":"138","author":"Ross","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.ecl.2006.06.005_bib6","first-page":"915","article-title":"Beyond cholesterol modifications of low-density lipoprotein that increase its atherogenicity","volume":"320","author":"Steinberg","year":"1989","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.ecl.2006.06.005_bib7","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1161\/01.ATV.16.7.831","article-title":"The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture","volume":"16","author":"Navab","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl 3","key":"10.1016\/j.ecl.2006.06.005_bib8","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/sj.ijo.0802501","article-title":"Inflammation and the IKK beta\/I kappa B\/NF-kappa B axis in obesity- and diet-induced insulin resistance","volume":"27","author":"Shoelson","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"2","key":"10.1016\/j.ecl.2006.06.005_bib9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.ecl.2006.06.005_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-Reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus","volume":"286","author":"Pradhan","year":"2001","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ecl.2006.06.005_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/01.CIR.102.1.42","article-title":"Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS)","volume":"102","author":"Festa","year":"2000","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ecl.2006.06.005_bib12","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.metabol.2004.02.004","article-title":"Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study","volume":"53","author":"Yudkin","year":"2004","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.ecl.2006.06.005_bib13","doi-asserted-by":"crossref","first-page":"H2031","DOI":"10.1152\/ajpheart.01058.2004","article-title":"Adipokines: molecular links between obesity and atheroslcerosis","volume":"288","author":"Lau","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"2","key":"10.1016\/j.ecl.2006.06.005_bib14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2169\/internalmedicine.38.202","article-title":"Role of adipocytokines on the pathogenesis of atherosclerosis in visceral obesity","volume":"38","author":"Funahashi","year":"1999","journal-title":"Intern Med"},{"issue":"10","key":"10.1016\/j.ecl.2006.06.005_bib15","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.2337\/diabetes.51.10.2951","article-title":"Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?","volume":"51","author":"Gabriely","year":"2002","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.ecl.2006.06.005_bib16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00041433-200202000-00008","article-title":"Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin","volume":"13","author":"Havel","year":"2002","journal-title":"Curr Opin Lipidol"},{"issue":"Suppl 2","key":"10.1016\/j.ecl.2006.06.005_bib17","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00005344-199500252-00003","article-title":"Cytokines regulate vascular functions related to stability of the atherosclerotic plaque","volume":"25","author":"Libby","year":"1995","journal-title":"J Cardiovasc Pharmacol"},{"issue":"1","key":"10.1016\/j.ecl.2006.06.005_bib18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0021-9150(01)00626-8","article-title":"Humoral markers of inflammation and endothelial dysfunction in relation to adiposity and in vivo insulin action in Pima Indians","volume":"161","author":"Weyer","year":"2002","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.ecl.2006.06.005_bib19","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/sj.ijo.0801792","article-title":"The relation of body fat mass and distribution to markers of chronic inflammation","volume":"25","author":"Festa","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"5","key":"10.1016\/j.ecl.2006.06.005_bib20","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/01.CIR.97.5.425","article-title":"Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.ecl.2006.06.005_bib21","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1161\/01.CIR.97.20.2007","article-title":"C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction","volume":"97","author":"Ridker","year":"1998","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ecl.2006.06.005_bib22","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1001\/jama.288.8.980","article-title":"Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study","volume":"288","author":"Pradhan","year":"2002","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.ecl.2006.06.005_bib23","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1001\/jama.285.19.2481","article-title":"Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease","volume":"285","author":"Ridker","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ecl.2006.06.005_bib24","doi-asserted-by":"crossref","first-page":"878","DOI":"10.2337\/diacare.28.4.878","article-title":"The metabolic syndrome and concentrations of C-reactive protein among US youth","volume":"28","author":"Ford","year":"2005","journal-title":"Diabetes Care"},{"issue":"3","key":"10.1016\/j.ecl.2006.06.005_bib25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.CIR.0000055014.62083.05","article-title":"C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ecl.2006.06.005_bib26","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.2337\/diacare.23.12.1835","article-title":"Association between C-reactive protein and features of the metabolic syndrome: a population-based study","volume":"23","author":"Frohlich","year":"2000","journal-title":"Diabetes Care"},{"issue":"Suppl 132","key":"10.1016\/j.ecl.2006.06.005_bib27","first-page":"31","article-title":"Metabolic syndrome, diabetes and coronary heart disease","volume":"56","author":"Haffner","year":"2002","journal-title":"Int J Clin Pract Suppl"},{"issue":"23","key":"10.1016\/j.ecl.2006.06.005_bib28","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1161\/01.CIR.0000041046.32962.86","article-title":"Differentiation between obesity and insulin resistance in the association with C-reactive protein","volume":"106","author":"McLaughlin","year":"2002","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ecl.2006.06.005_bib29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2337\/diabetes.53.3.585","article-title":"Discrimination between obesity and insulin resistance in the relationship with adiponectin","volume":"53","author":"Abbasi","year":"2004","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.ecl.2006.06.005_bib30","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2337\/diabetes.47.4.544","article-title":"Physiological insulinemia acutely modulates plasma leptin","volume":"47","author":"Saad","year":"1998","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.ecl.2006.06.005_bib31","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.2337\/diabetes.51.10.2968","article-title":"The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects","volume":"51","author":"Yu","year":"2002","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.ecl.2006.06.005_bib32","first-page":"499","article-title":"Endothelial Nuclear Factor-kB and the Initiation of the Atherosclerosis Lesion","volume":"68","author":"Collins","year":"1993","journal-title":"Lab Invest"},{"issue":"5","key":"10.1016\/j.ecl.2006.06.005_bib33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/00041433-199810000-00002","article-title":"The nuclear factor-kappa B\/inhibitor of kappa B autoregulatory system and atherosclerosis","volume":"9","author":"Thurberg","year":"1998","journal-title":"Curr Opin Lipidol"},{"issue":"16","key":"10.1016\/j.ecl.2006.06.005_bib34","doi-asserted-by":"crossref","first-page":"5308","DOI":"10.1093\/nar\/gki836","article-title":"NF-kappaB controls the global pro-inflammatory response in endothelial cells: evidence for the regulation of a pro-atherogenic program","volume":"33","author":"Kempe","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.ecl.2006.06.005_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0092-8674(00)81318-5","article-title":"NF-kappa B: ten years after","volume":"87","author":"Baeuerle","year":"1996","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ecl.2006.06.005_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/stke.1999.5.re1","article-title":"The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus","volume":"1999","author":"Rothwarf","year":"1999","journal-title":"Sci STKE"},{"issue":"4","key":"10.1016\/j.ecl.2006.06.005_bib37","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/ajcn\/79.4.682","article-title":"Increase in intranuclear nuclear factor kappaB and decrease in inhibitor kappaB in mononuclear cells after a mixed meal: evidence for a proinflammatory effect","volume":"79","author":"Aljada","year":"2004","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"10.1016\/j.ecl.2006.06.005_bib38","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.metabol.2003.10.013","article-title":"Differential effects of glucose and alcohol on reactive oxygen species generation and intranuclear nuclear factor-kappaB in mononuclear cells","volume":"53","author":"Dhindsa","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/j.ecl.2006.06.005_bib39","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1172\/JCI656","article-title":"Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-kB-dependent fashion","volume":"101","author":"Morigi","year":"1998","journal-title":"J Clin Invest"},{"issue":"23","key":"10.1016\/j.ecl.2006.06.005_bib40","doi-asserted-by":"crossref","first-page":"23942","DOI":"10.1074\/jbc.M312692200","article-title":"Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB","volume":"279","author":"Weigert","year":"2004","journal-title":"J Biol Chem"},{"issue":"3\u20134","key":"10.1016\/j.ecl.2006.06.005_bib41","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/ars.2005.7.395","article-title":"Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus","volume":"7","author":"Kabe","year":"2005","journal-title":"Antioxid Redox Signal"},{"issue":"17","key":"10.1016\/j.ecl.2006.06.005_bib42","doi-asserted-by":"crossref","first-page":"16971","DOI":"10.1074\/jbc.M312990200","article-title":"Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1","volume":"279","author":"Lee","year":"2004","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.ecl.2006.06.005_bib43","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1210\/jcem.85.8.6854","article-title":"Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes","volume":"85","author":"Mohanty","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.ecl.2006.06.005_bib44","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/ajcn\/75.4.767","article-title":"Both lipid and protein intakes stimulate increased generation of reactive oxygen species by polymorphonuclear leukocytes and mononuclear cells","volume":"75","author":"Mohanty","year":"2002","journal-title":"Am J Clin Nutr"},{"issue":"10","key":"10.1016\/j.ecl.2006.06.005_bib45","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1161\/01.CIR.0000027569.76671.A8","article-title":"Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment","volume":"106","author":"Ceriello","year":"2002","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ecl.2006.06.005_bib46","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s001250051058","article-title":"Is type II diabetes mellitus a disease of the innate immune system?","volume":"41","author":"Pickup","year":"1998","journal-title":"Diabetologia"},{"issue":"11","key":"10.1016\/j.ecl.2006.06.005_bib47","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.2337\/diab.43.11.1271","article-title":"Tumor necrosis factor alpha: a key component of the obesity-diabetes link","volume":"43","author":"Hotamisligil","year":"1994","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.ecl.2006.06.005_bib48","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2337\/diabetes.52.7.1799","article-title":"Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study","volume":"52","author":"Duncan","year":"2003","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.ecl.2006.06.005_bib49","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2337\/diabetes.51.4.1131","article-title":"Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study","volume":"51","author":"Festa","year":"2002","journal-title":"Diabetes"},{"issue":"5091","key":"10.1016\/j.ecl.2006.06.005_bib50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ecl.2006.06.005_bib51","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.4049\/jimmunol.172.4.2147","article-title":"Novel regulatory mechanisms of CD40-induced prostanoid synthesis by IL-4 and IL-10 in human monocytes","volume":"172","author":"Inoue","year":"2004","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.ecl.2006.06.005_bib52","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.2337\/diabetes.52.11.2784","article-title":"Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice","volume":"52","author":"Klover","year":"2003","journal-title":"Diabetes"},{"issue":"10","key":"10.1016\/j.ecl.2006.06.005_bib53","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/nm1001-1138","article-title":"Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle","volume":"7","author":"Perreault","year":"2001","journal-title":"Nat Med"},{"issue":"44","key":"10.1016\/j.ecl.2006.06.005_bib54","doi-asserted-by":"crossref","first-page":"42394","DOI":"10.1074\/jbc.C200444200","article-title":"SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2","volume":"277","author":"Rui","year":"2002","journal-title":"J Biol Chem"},{"issue":"9","key":"10.1016\/j.ecl.2006.06.005_bib55","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2337\/diab.46.9.1526","article-title":"Targeted disruption of the tumor necrosis factor-alpha gene: metabolic consequences in obese and nonobese mice","volume":"46","author":"Ventre","year":"1997","journal-title":"Diabetes"},{"issue":"15","key":"10.1016\/j.ecl.2006.06.005_bib56","doi-asserted-by":"crossref","first-page":"5634","DOI":"10.1073\/pnas.0401060101","article-title":"Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis","volume":"101","author":"Monaco","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.ecl.2006.06.005_bib57","first-page":"E83","article-title":"The transcription factor NF-kappa B and the regulation of vascular cell function","volume":"20","author":"De Martin","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.ecl.2006.06.005_bib58","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/01.RES.0000166924.31219.49","article-title":"Regulation of vascular smooth muscle cell proliferation: role of NF-kappaB revisited","volume":"96","author":"Mehrhof","year":"2005","journal-title":"Circ Res"},{"issue":"24","key":"10.1016\/j.ecl.2006.06.005_bib59","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1161\/01.CIR.0000146790.51331.BA","article-title":"Novel antiinflammatory vascular benefits of systemic and stent-based delivery of ethylisopropylamiloride","volume":"110","author":"Chen","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ecl.2006.06.005_bib60","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1253\/circj.68.270","article-title":"Initial clinical cases of the use of a NF-kappaB decoy at the site of coronary stenting for the prevention of restenosis","volume":"68","author":"Jun-Ichi","year":"2004","journal-title":"Circ J"},{"issue":"4","key":"10.1016\/j.ecl.2006.06.005_bib61","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0741-5214(03)00427-0","article-title":"Overexpression of mutated IkappaBalpha inhibits vascular smooth muscle cell proliferation and intimal hyperplasia formation","volume":"38","author":"Zuckerbraun","year":"2003","journal-title":"J Vasc Surg"},{"issue":"11","key":"10.1016\/j.ecl.2006.06.005_bib62","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/oby.2004.219","article-title":"Pleiotropic effects of genes for insulin resistance on adiposity in baboons","volume":"12","author":"Cai","year":"2004","journal-title":"Obes Res"},{"issue":"3","key":"10.1016\/j.ecl.2006.06.005_bib63","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1182\/blood-2003-05-1450","article-title":"Hematopoietic NF-kappaB1 deficiency results in small atherosclerotic lesions with an inflammatory phenotype","volume":"103","author":"Kanters","year":"2004","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.ecl.2006.06.005_bib64","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1172\/JCI200318580","article-title":"Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice","volume":"112","author":"Kanters","year":"2003","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.ecl.2006.06.005_bib65","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","article-title":"IKK-beta links inflammation to obesity-induced insulin resistance","volume":"11","author":"Arkan","year":"2005","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ecl.2006.06.005_bib66","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/nm1201-1291","article-title":"Possible new role for NF-kappaB in the resolution of inflammation","volume":"7","author":"Lawrence","year":"2001","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ecl.2006.06.005_bib67","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0095-4543(05)70130-5","article-title":"The natural history of type 2 diabetes. Implications for clinical practice","volume":"26","author":"Ramlo-Halsted","year":"1999","journal-title":"Prim Care"},{"issue":"7","key":"10.1016\/j.ecl.2006.06.005_bib68","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1249\/01.MSS.0000132387.25853.3B","article-title":"Sending the signal: molecular mechanisms regulating glucose uptake","volume":"36","author":"Krook","year":"2004","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.ecl.2006.06.005_bib69","first-page":"271","article-title":"Turning signals on and off: GLUT4 traffic in the insulin-signaling highway","volume":"20","author":"Thong","year":"2005","journal-title":"Physiology (Bethesda)"},{"issue":"4A","key":"10.1016\/j.ecl.2006.06.005_bib70","doi-asserted-by":"crossref","first-page":"10J","DOI":"10.1016\/S0002-9149(03)00611-8","article-title":"Role of endothelial dysfunction in insulin resistance","volume":"92","author":"Hsueh","year":"2003","journal-title":"Am J Cardiol"},{"issue":"1A","key":"10.1016\/j.ecl.2006.06.005_bib71","doi-asserted-by":"crossref","first-page":"21J","DOI":"10.1016\/S0002-9149(99)00353-7","article-title":"Insulin signaling in the arterial wall","volume":"84","author":"Hsueh","year":"1999","journal-title":"Am J Cardiol"},{"issue":"11 Pt 1","key":"10.1016\/j.ecl.2006.06.005_bib72","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0895-7061(03)01002-1","article-title":"Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension","volume":"16","author":"Catena","year":"2003","journal-title":"Am J Hypertens"},{"issue":"7","key":"10.1016\/j.ecl.2006.06.005_bib73","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1081\/CEH-120024983","article-title":"Renal angiotensin II receptors, hyperinsulinemia, and obesity","volume":"25","author":"Hussain","year":"2003","journal-title":"Clin Exp Hypertens"},{"issue":"5","key":"10.1016\/j.ecl.2006.06.005_bib74","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/er.2001-0039","article-title":"Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes","volume":"23","author":"Evans","year":"2002","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.ecl.2006.06.005_bib75","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1172\/JCI7535","article-title":"Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle","volume":"105","author":"Cusi","year":"2000","journal-title":"J Clin Invest"},{"issue":"4\u20135","key":"10.1016\/j.ecl.2006.06.005_bib76","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/15216540500097111","article-title":"From JNK to pay dirt: jun kinases, their biochemistry, physiology and clinical importance","volume":"57","author":"Karin","year":"2005","journal-title":"IUBMB Life"},{"issue":"5","key":"10.1016\/j.ecl.2006.06.005_bib77","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1111\/j.1523-1755.2004.00576.x","article-title":"BMK1 is activated in glomeruli of diabetic rats and in mesangial cells by high glucose conditions","volume":"65","author":"Suzaki","year":"2004","journal-title":"Kidney Int"},{"issue":"2","key":"10.1016\/j.ecl.2006.06.005_bib78","doi-asserted-by":"crossref","first-page":"89","DOI":"10.4067\/S0716-97602000000200008","article-title":"Endothelial cell oxidative stress and signal transduction","volume":"33","author":"Foncea","year":"2000","journal-title":"Biol Res"},{"issue":"4","key":"10.1016\/j.ecl.2006.06.005_bib79","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1161\/01.HYP.35.4.942","article-title":"Role of reactive oxygen species in bradykinin-induced mitogen-activated protein kinase and c-fos induction in vascular cells","volume":"35","author":"Greene","year":"2000","journal-title":"Hypertension"},{"issue":"1\u20133","key":"10.1016\/j.ecl.2006.06.005_bib80","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(03)00846-9","article-title":"The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site","volume":"550","author":"Ishihara","year":"2003","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ecl.2006.06.005_bib81","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbapap.2005.08.017","article-title":"MAPK signalling pathways as molecular targets for anti-inflammatory therapy-from molecular mechanisms to therapeutic benefits","volume":"1754","author":"Kaminska","year":"2005","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"10.1016\/j.ecl.2006.06.005_bib82","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nrd1132","article-title":"Targeting JNK for therapeutic benefit: from junk to gold?","volume":"2","author":"Manning","year":"2003","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"10.1016\/j.ecl.2006.06.005_bib83","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0024-3205(02)02182-3","article-title":"Glucose upregulates plasminogen activator inhibitor-1 gene expression in vascular smooth muscle cells","volume":"72","author":"Suzuki","year":"2002","journal-title":"Life Sci"},{"issue":"7","key":"10.1016\/j.ecl.2006.06.005_bib84","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.RES.0000124920.09738.26","article-title":"Glucose enhances human macrophage LOX-1 expression: role for LOX-1 in glucose-induced macrophage foam cell formation","volume":"94","author":"Li","year":"2004","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.ecl.2006.06.005_bib85","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.4049\/jimmunol.172.6.3758","article-title":"The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes","volume":"172","author":"Bowdish","year":"2004","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.ecl.2006.06.005_bib86","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1172\/JCI3326","article-title":"Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways","volume":"103","author":"Igarashi","year":"1999","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.ecl.2006.06.005_bib87","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0003-9861(02)00028-0","article-title":"Vascular smooth muscle cell proliferation requires both p38 and BMK1 MAP kinases","volume":"400","author":"Zhao","year":"2002","journal-title":"Arch Biochem Biophys"},{"issue":"11","key":"10.1016\/j.ecl.2006.06.005_bib88","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1161\/01.ATV.0000144009.35400.65","article-title":"Altered PDGF-BB-induced p38 MAP kinase activation in diabetic vascular smooth muscle cells: roles of protein kinase C-delta","volume":"24","author":"Yamaguchi","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.ecl.2006.06.005_bib89","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijcard.2004.08.039","article-title":"Insulin resistance as a predictor for restenosis after coronary stenting","volume":"103","author":"Nishio","year":"2005","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ecl.2006.06.005_bib90","first-page":"85","article-title":"High glucose-induced activation of protein kinase signaling pathways in vascular smooth muscle cells: a potential role in the pathogenesis of vascular dysfunction in diabetes (review)","volume":"9","author":"Srivastava","year":"2002","journal-title":"Int J Mol Med"},{"issue":"8","key":"10.1016\/j.ecl.2006.06.005_bib91","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1046\/j.1365-2362.2000.00671.x","article-title":"Insulin activates p38 mitogen-activated protein (MAP) kinase via a MAP kinase kinase (MKK) 3\/MKK 6 pathway in vascular smooth muscle cells","volume":"30","author":"Igarashi","year":"2000","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"10.1016\/j.ecl.2006.06.005_bib92","first-page":"84","article-title":"The proinflammatory and hypercoagulable state of diabetes mellitus","volume":"6","author":"Aras","year":"2005","journal-title":"Rev Cardiovasc Med"},{"issue":"4","key":"10.1016\/j.ecl.2006.06.005_bib93","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.ccl.2004.06.009","article-title":"Platelet function, coagulopathy, and impaired fibrinolysis in diabetes","volume":"22","author":"Sobel","year":"2004","journal-title":"Cardiol Clin"},{"issue":"12","key":"10.1016\/j.ecl.2006.06.005_bib94","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1161\/01.RES.0000171805.24799.fa","article-title":"Procoagulant soluble tissue factor is released from endothelial cells in response to inflammatory cytokines","volume":"96","author":"Szotowski","year":"2005","journal-title":"Circ Res"},{"issue":"1","key":"10.1016\/j.ecl.2006.06.005_bib95","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2337\/diabetes.54.1.85","article-title":"Hyperglycemia induces monocytic release of interleukin-6 via induction of protein kinase c-{alpha} and -{beta}","volume":"54","author":"Devaraj","year":"2005","journal-title":"Diabetes"},{"issue":"11","key":"10.1016\/j.ecl.2006.06.005_bib96","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1007\/s00125-003-1223-4","article-title":"MAP kinases and mTOR mediate insulin-induced phosphorylation of insulin receptor substrate-1 on serine residues 307, 612 and 632","volume":"46","author":"Gual","year":"2003","journal-title":"Diabetologia"},{"issue":"21","key":"10.1016\/j.ecl.2006.06.005_bib97","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1007\/s00018-005-5253-6","article-title":"\u201cJnking\u201d atherosclerosis","volume":"62","author":"Sumara","year":"2005","journal-title":"Cell Mol Life Sci"},{"issue":"6913","key":"10.1016\/j.ecl.2006.06.005_bib98","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/nature01137","article-title":"A central role for JNK in obesity and insulin resistance","volume":"420","author":"Hirosumi","year":"2002","journal-title":"Nature"},{"issue":"Suppl 3","key":"10.1016\/j.ecl.2006.06.005_bib99","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.1038\/sj.ijo.0802502","article-title":"Inflammatory pathways and insulin action","volume":"27","author":"Hotamisligil","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"3","key":"10.1016\/j.ecl.2006.06.005_bib100","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ijc.11413","article-title":"ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells","volume":"107","author":"Zelivianski","year":"2003","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.ecl.2006.06.005_bib101","doi-asserted-by":"crossref","first-page":"F166","DOI":"10.1152\/ajprenal.00401.2004","article-title":"p38 MAP kinase inhibition ameliorates cisplatin nephrotoxicity in mice","volume":"289","author":"Ramesh","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"issue":"6","key":"10.1016\/j.ecl.2006.06.005_bib102","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.fct.2005.11.007","article-title":"alpha-Chaconine, a potato glycoalkaloid, induces apoptosis of HT-29 human colon cancer cells through caspase-3 activation and inhibition of ERK 1\/2 phosphorylation","volume":"44","author":"Yang","year":"2006","journal-title":"Food Chem Toxicol"},{"issue":"9","key":"10.1016\/j.ecl.2006.06.005_bib103","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/ijc.21615","article-title":"A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: implication in tumor angiogenesis","volume":"118","author":"Lamy","year":"2006","journal-title":"Int J Cancer"},{"issue":"9","key":"10.1016\/j.ecl.2006.06.005_bib104","first-page":"455","article-title":"Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage","volume":"26","author":"Waetzig","year":"2005","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.ecl.2006.06.005_bib105","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/dmrr.431","article-title":"The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinopathy","volume":"20","author":"Curtis","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"issue":"9","key":"10.1016\/j.ecl.2006.06.005_bib106","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1073\/pnas.88.9.3997","article-title":"Identification of intracellular receptor proteins for activated protein kinase C","volume":"88","author":"Mochly-Rosen","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6A","key":"10.1016\/j.ecl.2006.06.005_bib107","doi-asserted-by":"crossref","first-page":"9H","DOI":"10.1016\/S0002-9149(01)01831-8","article-title":"Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus","volume":"88","author":"Ginsberg","year":"2001","journal-title":"Am J Cardiol"},{"issue":"6A","key":"10.1016\/j.ecl.2006.06.005_bib108","doi-asserted-by":"crossref","first-page":"20H","DOI":"10.1016\/S0002-9149(01)01833-1","article-title":"Effect of the postprandial state on nontraditional risk factors","volume":"88","author":"Lebovitz","year":"2001","journal-title":"Am J Cardiol"},{"issue":"1","key":"10.1016\/j.ecl.2006.06.005_bib109","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.54.1.1","article-title":"Postprandial hyperglycemia and diabetes complications: is it time to treat?","volume":"54","author":"Ceriello","year":"2005","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.ecl.2006.06.005_bib110","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1210\/endo-128-6-2937","article-title":"Interrelated effects of insulin and glucose on diacylglycerol-protein kinase-C signalling in rat adipocytes and solei muscle in vitro and in vivo in diabetic rats","volume":"128","author":"Hoffman","year":"1991","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.ecl.2006.06.005_bib111","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.2337\/diab.43.9.1122","article-title":"Characterization of the mechanism for the chronic activation of diacylglycerol-protein kinase C pathway in diabetes and hypergalactosemia","volume":"43","author":"Xia","year":"1994","journal-title":"Diabetes"},{"issue":"5","key":"10.1016\/j.ecl.2006.06.005_bib112","doi-asserted-by":"crossref","first-page":"E685","DOI":"10.1152\/ajpendo.2001.280.5.E685","article-title":"Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE","volume":"280","author":"Wautier","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"13","key":"10.1016\/j.ecl.2006.06.005_bib113","doi-asserted-by":"crossref","first-page":"9889","DOI":"10.1016\/S0021-9258(17)36966-1","article-title":"Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors\/binding proteins","volume":"269","author":"Yan","year":"1994","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.ecl.2006.06.005_bib114","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0022-2275(20)37569-6","article-title":"Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis","volume":"37","author":"Goldberg","year":"1996","journal-title":"J Lipid Res"},{"issue":"9","key":"10.1016\/j.ecl.2006.06.005_bib115","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1016\/S0021-9258(19)41531-7","article-title":"Hydrolysis of diacylglycerols by lipoprotein lipase","volume":"250","author":"Morley","year":"1975","journal-title":"J Biol Chem"},{"issue":"10","key":"10.1016\/j.ecl.2006.06.005_bib116","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1139\/o77-159","article-title":"Preferential in vivo accumulation of sn-2, 3-diacylglycerols in postheparin plasma of rats","volume":"55","author":"Morley","year":"1977","journal-title":"Can J Biochem"},{"issue":"2","key":"10.1016\/j.ecl.2006.06.005_bib117","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2362.1999.00438.x","article-title":"Distribution of diacylglycerols among plasma lipoproteins in control subjects and in patients with non-insulin-dependent diabetes","volume":"29","author":"Lalanne","year":"1999","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"10.1016\/j.ecl.2006.06.005_bib118","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s109-1998-8101-y","article-title":"Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus","volume":"76","author":"Ishii","year":"1998","journal-title":"J Mol Med"},{"issue":"Pt 1","key":"10.1016\/j.ecl.2006.06.005_bib119","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1042\/bj3570275","article-title":"Fatty acids inhibit growth-factor-induced diacylglycerol kinase alpha activation in vascular smooth-muscle cells","volume":"357","author":"Du","year":"2001","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.ecl.2006.06.005_bib120","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0898-6568(94)00089-T","article-title":"Arachidonic acid and free fatty acids as second messengers and the role of protein kinase C","volume":"7","author":"Khan","year":"1995","journal-title":"Cell Signal"},{"issue":"4649","key":"10.1016\/j.ecl.2006.06.005_bib121","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.6231726","article-title":"A potential second messenger role for unsaturated fatty acids: activation of Ca2+dependent protein kinase","volume":"224","author":"McPhail","year":"1984","journal-title":"Science"},{"issue":"27","key":"10.1016\/j.ecl.2006.06.005_bib122","doi-asserted-by":"crossref","first-page":"16437","DOI":"10.1016\/S0021-9258(17)46241-7","article-title":"Regulation of platelet protein kinase C by oleic acid. Kinetic analysis of allosteric regulation and effects on autophosphorylation, phorbol ester binding, and susceptibility to inhibition","volume":"265","author":"el Touny","year":"1990","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.ecl.2006.06.005_bib123","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1210\/endo.141.6.7493","article-title":"Long-chain acyl CoA regulation of protein kinase C\u00a0and fatty acid potentiation of glucose-stimulated insulin secretion in clonal beta-cells","volume":"141","author":"Yaney","year":"2000","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.ecl.2006.06.005_bib124","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3109\/10715769509147525","article-title":"Oxidant-induced activation of protein kinase C in UC11MG cells","volume":"22","author":"Brawn","year":"1995","journal-title":"Free Radic Res"},{"issue":"17","key":"10.1016\/j.ecl.2006.06.005_bib125","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1073\/pnas.86.17.6758","article-title":"Ca2+ and phospholipid-independent activation of protein kinase C by selective oxidative modification of the regulatory domain","volume":"86","author":"Gopalakrishna","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.ecl.2006.06.005_bib126","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/0006-291X(92)90463-U","article-title":"Oxidation-induced persistent activation of protein kinase C in hippocampal homogenates","volume":"187","author":"Palumbo","year":"1992","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.ecl.2006.06.005_bib127","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1006\/abbi.1995.1263","article-title":"Sublethal levels of oxidant stress stimulate multiple serine\/threonine kinases and suppress protein phosphatases in Jurkat T cells","volume":"319","author":"Whisler","year":"1995","journal-title":"Arch Biochem Biophys"},{"issue":"2","key":"10.1016\/j.ecl.2006.06.005_bib128","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0003-9861(91)90377-U","article-title":"Reversible oxidative activation and inactivation of protein kinase C by the mitogen\/tumor promoter periodate","volume":"285","author":"Gopalakrishna","year":"1991","journal-title":"Arch Biochem Biophys"},{"issue":"9","key":"10.1016\/j.ecl.2006.06.005_bib129","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0891-5849(00)00221-5","article-title":"Protein kinase C signaling and oxidative stress","volume":"28","author":"Gopalakrishna","year":"2000","journal-title":"Free Radic Biol Med"},{"issue":"12","key":"10.1016\/j.ecl.2006.06.005_bib130","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1073\/pnas.111158798","article-title":"Phosphorylation sites of protein kinase C delta in H2O2-treated cells and its activation by tyrosine kinase in vitro","volume":"98","author":"Konishi","year":"2001","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"3","key":"10.1016\/j.ecl.2006.06.005_bib131","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1006\/bbrc.2000.3048","article-title":"(2)O(2)-induced tyrosine phosphorylation of protein kinase cdelta by a mechanism independent of inhibition of protein-tyrosine phosphatase in CHO and COS-7 cells","volume":"273","author":"Yamamoto","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"issue":"12","key":"10.1016\/j.ecl.2006.06.005_bib132","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1046\/j.0742-3071.2001.00638.x","article-title":"Protein kinase C and the development of diabetic vascular complications","volume":"18","author":"Way","year":"2001","journal-title":"Diabet Med"},{"issue":"4","key":"10.1016\/j.ecl.2006.06.005_bib133","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2174\/1389450054021990","article-title":"Molecular targets of diabetic cardiovascular complications","volume":"6","author":"Ahmad","year":"2005","journal-title":"Curr Drug Targets"},{"issue":"3","key":"10.1016\/j.ecl.2006.06.005_bib134","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1161\/01.ATV.0000155325.41507.e0","article-title":"Proatherosclerotic mechanisms involving protein kinase C in diabetes and insulin resistance","volume":"25","author":"Rask-Madsen","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.ecl.2006.06.005_bib135","doi-asserted-by":"crossref","first-page":"859","DOI":"10.2337\/diabetes.47.6.859","article-title":"Protein kinase C activation and the development of diabetic complications","volume":"47","author":"Koya","year":"1998","journal-title":"Diabetes"},{"issue":"Suppl 3","key":"10.1016\/j.ecl.2006.06.005_bib136","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.2337\/diab.45.3.S105","article-title":"Biochemical and molecular mechanisms in the development of diabetic vascular complications","volume":"45","author":"King","year":"1996","journal-title":"Diabetes"},{"issue":"2","key":"10.1016\/j.ecl.2006.06.005_bib137","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0889-8529(05)70324-8","article-title":"The cellular and molecular mechanisms of diabetic complications","volume":"25","author":"King","year":"1996","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"10.1016\/j.ecl.2006.06.005_bib138","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1189\/jlb.0804442","article-title":"Structural organization of the neutrophil NADPH oxidase: phosphorylation and translocation during priming and activation","volume":"78","author":"Sheppard","year":"2005","journal-title":"J Leukoc Biol"},{"issue":"8, Suppl 3","key":"10.1016\/j.ecl.2006.06.005_bib139","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1097\/01.ASN.0000077407.90309.65","article-title":"Protein kinase C-dependent increase in reactive oxygen species (ROS) production in vascular tissues of diabetes: role of vascular NAD(P)H oxidase","volume":"14","author":"Inoguchi","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ecl.2006.06.005_bib140","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2174\/1389450054021927","article-title":"NAD(P)H oxidase activation: a potential target mechanism for diabetic vascular complications, progressive beta-cell dysfunction and metabolic syndrome","volume":"6","author":"Inoguchi","year":"2005","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.ecl.2006.06.005_bib141","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1475-2840-1-1","article-title":"How hyperglycemia promotes atherosclerosis: molecular mechanisms","volume":"1","author":"Aronson","year":"2002","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"10.1016\/j.ecl.2006.06.005_bib142","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2337\/diabetes.54.6.1615","article-title":"The pathobiology of diabetic complications: a unifying mechanism","volume":"54","author":"Brownlee","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ecl.2006.06.005_bib143","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1046\/j.1523-1755.2000.07705.x","article-title":"The missing link: a single unifying mechanism for diabetic complications","volume":"77","author":"Nishikawa","year":"2000","journal-title":"Kidney Int Suppl"},{"issue":"2","key":"10.1016\/j.ecl.2006.06.005_bib144","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s11906-005-0090-4","article-title":"Cellular mechanisms and treatment of diabetes vascular complications converge on reactive oxygen species","volume":"7","author":"Whiteside","year":"2005","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"10.1016\/j.ecl.2006.06.005_bib145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11906-004-0081-x","article-title":"Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus","volume":"6","author":"Endemann","year":"2004","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.ecl.2006.06.005_bib146","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1055\/s-2007-979997","article-title":"Effect of troglitazone, a new oral antidiabetic agent, on fructose-induced insulin resistance","volume":"27","author":"Yagi","year":"1995","journal-title":"Horm Metab Res"},{"issue":"5","key":"10.1016\/j.ecl.2006.06.005_bib147","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1161\/01.ATV.0000122852.22604.78","article-title":"Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited","volume":"24","author":"Ceriello","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.ecl.2006.06.005_bib148","first-page":"3257","article-title":"Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect?","volume":"86","author":"Dandona","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.ecl.2006.06.005_bib149","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1523-1755.2005.00257.x","article-title":"The sources of oxidative stress in the vessel wall","volume":"67","author":"Wolin","year":"2005","journal-title":"Kidney Int"},{"issue":"Suppl 1","key":"10.1016\/j.ecl.2006.06.005_bib150","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.2337\/diabetes.53.2007.S110","article-title":"Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes","volume":"53","author":"Green","year":"2004","journal-title":"Diabetes"},{"issue":"1","key":"10.1016\/j.ecl.2006.06.005_bib151","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajh.2830040102","article-title":"Superoxide generation by human monocytes and macrophages","volume":"4","author":"Weiss","year":"1978","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.ecl.2006.06.005_bib152","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1172\/JCI18127","article-title":"Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells","volume":"112","author":"Du","year":"2003","journal-title":"J Clin Invest"},{"issue":"41","key":"10.1016\/j.ecl.2006.06.005_bib153","doi-asserted-by":"crossref","first-page":"42351","DOI":"10.1074\/jbc.R400019200","article-title":"Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes","volume":"279","author":"Robertson","year":"2004","journal-title":"J Biol Chem"},{"issue":"8","key":"10.1016\/j.ecl.2006.06.005_bib154","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.CIR.0000027109.14149.67","article-title":"Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase","volume":"106","author":"Lin","year":"2002","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ecl.2006.06.005_bib155","doi-asserted-by":"crossref","first-page":"976","DOI":"10.2337\/diab.21.9.976","article-title":"A summary of criticisms of the findings and conclusions of the University Group Diabetes Program (UGDP)","volume":"21","author":"Seltzer","year":"1972","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.ecl.2006.06.005_bib156","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2337\/diacare.18.8.1113","article-title":"Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes","volume":"18","author":"Abraira","year":"1995","journal-title":"Diabetes Care"},{"issue":"9131","key":"10.1016\/j.ecl.2006.06.005_bib157","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","author":"UK Prospective Diabetes Study (UKPDS) Group","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ecl.2006.06.005_bib158","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s11373-005-1703-2","article-title":"Reactive oxygen species and ERK 1\/2 mediate monocyte chemotactic protein-1-stimulated smooth muscle cell migration","volume":"12","author":"Lo","year":"2005","journal-title":"J Biomed Sci"},{"issue":"4","key":"10.1016\/j.ecl.2006.06.005_bib159","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/jcb.1198","article-title":"Multiple role of reactive oxygen species in the arterial wall","volume":"82","author":"Napoli","year":"2001","journal-title":"J Cell Biochem"},{"issue":"10","key":"10.1016\/j.ecl.2006.06.005_bib160","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI0214955","article-title":"Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes","volume":"109","author":"Hundal","year":"2002","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"10.1016\/j.ecl.2006.06.005_bib161","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/B:MCBI.0000041861.79585.4b","article-title":"PPAR-gamma receptor agonists\u2013a review of their role in diabetic management in Trinidad and Tobago","volume":"263","author":"Smith","year":"2004","journal-title":"Mol Cell Biochem"},{"issue":"7","key":"10.1016\/j.ecl.2006.06.005_bib162","first-page":"250","article-title":"Anti-inflammatory effects of troglitazone in nondiabetic obese subjects independent of changes in insulin sensitivity","volume":"63","author":"van Tits","year":"2005","journal-title":"Neth J Med"},{"issue":"4","key":"10.1016\/j.ecl.2006.06.005_bib163","doi-asserted-by":"crossref","first-page":"844","DOI":"10.2337\/diacare.28.4.844","article-title":"Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes","volume":"28","author":"van Wijk","year":"2005","journal-title":"Diabetes Care"},{"issue":"9004","key":"10.1016\/j.ecl.2006.06.005_bib164","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(96)90866-1","article-title":"Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)","volume":"347","author":"Stephens","year":"1996","journal-title":"Lancet"},{"issue":"9067","key":"10.1016\/j.ecl.2006.06.005_bib165","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0140-6736(97)01234-8","article-title":"Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction","volume":"349","author":"Rapola","year":"1997","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ecl.2006.06.005_bib166","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1047-2797(99)00042-3","article-title":"Design of Physicians' Health Study II:\u2013a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials","volume":"10","author":"Christen","year":"2000","journal-title":"Ann Epidemiol"},{"issue":"1","key":"10.1016\/j.ecl.2006.06.005_bib167","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.294.1.56","article-title":"Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial","volume":"294","author":"Lee","year":"2005","journal-title":"JAMA"},{"issue":"42","key":"10.1016\/j.ecl.2006.06.005_bib168","doi-asserted-by":"crossref","first-page":"26149","DOI":"10.1074\/jbc.271.42.26149","article-title":"Manganese-based superoxide dismutase mimetics inhibit neutrophil infiltration in vivo","volume":"271","author":"Weiss","year":"1996","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.ecl.2006.06.005_bib169","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.bjp.0703775","article-title":"Protective effects of a new stable, highly active SOD mimetic, M40401 in splanchnic artery occlusion and reperfusion","volume":"132","author":"Cuzzocrea","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.ecl.2006.06.005_bib170","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.bjp.0703841","article-title":"Pharmacological manipulation of the inflammatory cascade by the superoxide dismutase mimetic, M40403","volume":"132","author":"Salvemini","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.ecl.2006.06.005_bib171","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.1161\/01.RES.88.2.e14","article-title":"Mechanisms underlying endothelial dysfunction in diabetes mellitus","volume":"88","author":"Hink","year":"2001","journal-title":"Circ Res"},{"issue":"28","key":"10.1016\/j.ecl.2006.06.005_bib172","doi-asserted-by":"crossref","first-page":"19034","DOI":"10.1016\/S0021-9258(18)55168-1","article-title":"Regulation of endothelin-1 gene expression by Fos and Jun","volume":"266","author":"Lee","year":"1991","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.ecl.2006.06.005_bib173","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/01.CIR.0000133384.38551.A8","article-title":"Selective inhibition of protein kinase Cbeta2 prevents acute effects of high glucose on vascular cell adhesion molecule-1 expression in human endothelial cells","volume":"110","author":"Kouroedov","year":"2004","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ecl.2006.06.005_bib174","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S1056-8727(01)00163-5","article-title":"Participation of high glucose concentrations in neutrophil adhesion and surface expression of adhesion molecules on cultured human endothelial cells: effect of antidiabetic medicines","volume":"16","author":"Omi","year":"2002","journal-title":"J Diabetes Complications"},{"issue":"7","key":"10.1016\/j.ecl.2006.06.005_bib175","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/01.RES.87.7.574","article-title":"Hyperglycemia inhibits vascular smooth muscle cell apoptosis through a protein kinase C-dependent pathway","volume":"87","author":"Hall","year":"2000","journal-title":"Circ Res"},{"issue":"7","key":"10.1016\/j.ecl.2006.06.005_bib176","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1161\/01.CIR.0000051367.92927.07","article-title":"High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species","volume":"107","author":"Cosentino","year":"2003","journal-title":"Circulation"}],"container-title":["Endocrinology and Metabolism Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852906000454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889852906000454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:29:58Z","timestamp":1760174998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889852906000454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":176,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0889852906000454"],"URL":"https:\/\/doi.org\/10.1016\/j.ecl.2006.06.005","relation":{},"ISSN":["0889-8529"],"issn-type":[{"value":"0889-8529","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular and Signaling Mechanisms of Atherosclerosis in Insulin Resistance","name":"articletitle","label":"Article Title"},{"value":"Endocrinology and Metabolism Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ecl.2006.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}